EUTM file information

018559880

REWRITE

September 15, 2021

Trademark Summary

The trademark application REWRITE was filed by Rewrite Therapeutics, Inc., a U.S. corporation (the "Applicant"). Application withdrawn.

The application was filed in English (German was selected as the second language).

The Refusal with reference B 018559880 was Rejected according to Article 7(1)(b) EUTMR with decision issued on March 27, 2022 by the EUIPO.

Goods And Services

  • The mark was filed in class 5 with CRISPR-based products for the treatment of genetic diseases.
  • The mark was filed in class 42 with Medical and scientific research in the field of genetic engineering, namely, development of CRISPR-based platforms and products.